(14971513), A. O., (14971516), R. C., (14971519), G. v. A., (14971522), C. R., (14971525), S. F., (14971528), W. L., . . . (14971558), M. J. (2025). Supplementary Table S1 from Randomized Phase II Cabazitaxel Dose Individualization and Neutropenia Prevention Trial in Patients with Metastatic Castration-Resistant Prostate Cancer.
Citazione stile Chigago Style (17a edizione)(14971513), Aurelius Omlin, et al. Supplementary Table S1 from Randomized Phase II Cabazitaxel Dose Individualization and Neutropenia Prevention Trial in Patients with Metastatic Castration-Resistant Prostate Cancer. 2025.
Citatione MLA (9a ed.)(14971513), Aurelius Omlin, et al. Supplementary Table S1 from Randomized Phase II Cabazitaxel Dose Individualization and Neutropenia Prevention Trial in Patients with Metastatic Castration-Resistant Prostate Cancer. 2025.